eugeni purchase, page-20

With all the M & A going on , I heard https://www.quagenpharma.com/ $10 billion + market cap is an Ellume bond holder that will convert to 15% share of Elume at the end of this year,

Ellume has to be a takeover target , I thought the obvious buyer was Quidel Corporation (QDEL) market cap $5 + billion , with its antigen test netting $700 million per quarter would be a taker just to protect market share, Ellume has an FDA approved rapid Antigen test , a USD$300 million grant and sale large contacts, maybe its Quagen? must be tempting to both.

Anteo tech has leverage over Ellume , the new Anteo/ Ellume supply contract is up in October and must be a part of any Ellume takeover negotiations particularly when Anteotech has a very important part of the test that makes it work, I think with a bit of luck a better Ellume deal will come ? could be wrong , just my suspicious mind at work.